Results 281 to 290 of about 28,823 (297)

Ameliorating effect of the novel dipeptidyl peptidase‐4 inhibitor teneligliptin on psoriasis: A report of two cases

Journal of Dermatology, 2015
Hiroshi Nagai, Susumu Fujiwara
exaly  

Dipeptidyl Peptidase-4 Inhibitor–Associated Pancreatic Carcinoma

Annals of Pharmacotherapy, 2016
Angela K Nagel, Robbert P Van Manen
exaly  

Synthesis of a Dipeptidyl Peptidase-4 Inhibitor

Synfacts, 2019
openaire   +1 more source

Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling

European Journal of Medicinal Chemistry, 2017
Dean Rea, Hans De Winter, Bart Landuyt   +2 more
exaly  

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

Current Medical Research and Opinion, 2009
Richard E Pratley, Jane E B Reusch
exaly  

Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits

Journal of the American Heart Association, 2017
Yungang Zhao, Ning Jiang, Jiuchun Qiu
exaly  

Dipeptidyl peptidase-4 inhibitors/metformin

Reactions Weekly, 2018
openaire   +1 more source

Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

Expert Opinion on Pharmacotherapy, 2009
Richard E Pratley
exaly  

The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells

Tumor Biology, 2017
Si Hyoung Kim, Jun Goo Kang, Sung-Hee Ihm   +2 more
exaly  

Analyzing a dipeptide library to identify human dipeptidyl peptidase IV inhibitor

Food Chemistry, 2015
Keisuke Itô, Sohei Itô, Yasuaki Kawarasaki   +2 more
exaly